Ishita Drugs & Industries Ltd

BSE: 524400

112

total announcements

ISHITADR.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 07 Nov 2026

Market Cap

₹21 Cr

P/E (TTM)

30.1

EPS (TTM)

₹2.36

52W Low

₹66.00

52W High

₹90.85

Dividend Yield

0.00%

Price / Book

1.8

Return on Equity

6.24%

Debt / Equity

0.0

Revenue (TTM)

₹12 Cr

Gross Margin

16.74%

Operating Margin

9.75%

Announcements Discussion

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its statutory auditor.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its statutory auditor.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of Statutory Auditor.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its statutory auditor.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its statutory auditor.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its statutory auditor.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed about the re-appointment of its statutory auditor.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its statutory auditor.

BSECompany UpdateMgmt Change2 Oct 2026

Ishita Drugs & Industries Ltd

1. Approval of re-appointment of Mrs. Abha Agrawal (DIN: 01589479) as a Non Executive Non-Independent Director of the Company post attaining the age of 75 years , and who retires by rotation, being eligible offers herself for re-appointment. 2. Approval of re-appointment of M/s. Jaymin Shah & Assocites, Chartered Accountants as the statutory auditor of the company for the FY 2026-27

Ishita Drugs & Industries Ltd has announced the re-appointment of Mrs. Abha Agrawal as a Non-Executive Non-Independent Director and M/s. Jaymin Shah & Associates as the Statutory Auditor for FY 2026-27.

Read more →📎 1 attachment

BSECompany UpdateAuditor Change2 Oct 2026

Ishita Drugs & Industries Ltd

Re-appointment of M/s. Jaymin Shah & Associates, Chartered Accountants (FRN: 129406W) as a statutory Auditor of the Company for the FY 2026-27.

Ishita Drugs & Industries Ltd has re-appointed M/s. Jaymin Shah & Associates as its statutory auditor for FY 2026-27.

Read more →📎 1 attachment

BSEAGM/EGMMgmt Change2 Oct 2026

Ishita Drugs & Industries Ltd

Disclosure of Voting Results and Scrutinizer''s Report for 33rd Annual General Meeting of the Company held on Wednesday, 30th September, 2026.

Ishita Drugs & Industries Ltd has announced the voting results and scrutinizer's report for its 33rd Annual General Meeting held on September 30, 2026. The meeting passed all the business items with the requisite majority, including the re-appointment of a non-executive director and the approval of related party transactions.

Read more →📎 1 attachment

BSEAGM/EGMMgmt Change30 Sept 2026

Ishita Drugs & Industries Ltd

Proceedings of the 33rd Annual General Meeting of the Company held on 30th September, 2026 at 11:30 A.M. and concluded on 12:30 P.M.

Ishita Drugs & Industries Ltd held its 33rd Annual General Meeting on September 30, 2026, where 32 members attended in person. The meeting approved several resolutions, including the re-appointment of a non-executive director and related party transactions. The company also extended the facility of E-Voting/ Remote Voting to its members.

Read more →📎 1 attachment

← PreviousPage 5 of 6Next →